Muromachi Chemicals
4885.TPharmaceutical
In English · 1
Mon, Apr 27 · JST1 filing
17:025% STAKEMuromachi Chemicals · Tetsuro Murayama · 14.89% → 10.01%−4.88ppAll EDINET filings · 42
| Filed | Document | Source |
|---|---|---|
| 2026-08-25 | Internal control report | S100YYCD |
| 2026-08-25 | CEO/CFO certification | S100YYCA |
| 2026-01-14 | CEO/CFO certification | S100XFRC |
| 2025-08-26 | Internal control report | S100WL9J |
| 2025-08-26 | CEO/CFO certification | S100WL9I |
| 2025-01-14 | CEO/CFO certification | S100V2KA |
| 2024-08-28 | Internal control report | S100UA7F |
| 2024-08-28 | CEO/CFO certification | S100UA7D |
| 2024-04-12 | CEO/CFO certification | S100T9HX |
| 2024-01-12 | CEO/CFO certification | S100SLIS |
| 2023-10-13 | CEO/CFO certification | S100S0P6 |
| 2023-08-25 | Internal control report | S100RQQP |
| 2023-08-25 | CEO/CFO certification | S100RQQM |
| 2022-08-26 | Internal control report | S100P2V8 |
| 2022-08-26 | CEO/CFO certification | S100P2V7 |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 5 financial reports not structured yet.